{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:36:13Z","timestamp":1787002573779,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T00:00:00Z","timestamp":1358208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T00:00:00Z","timestamp":1358208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/mp.2012.172","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T04:35:58Z","timestamp":1358224558000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy"],"prefix":"10.1038","volume":"19","author":[{"given":"A","family":"Reif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Lueken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T","family":"Gloster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G W","family":"Alpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-U","family":"Wittchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,15]]},"reference":[{"key":"BFmp2012172_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655\u2013679.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp2012172_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/7854_2011_185","volume":"12","author":"K Domschke","year":"2012","unstructured":"Domschke K, Reif A . Behavioral genetics of affective and anxiety disorders. Curr Top Behav Neurosci 2012; 12: 463\u2013502.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFmp2012172_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/mp.2010.41","volume":"16","author":"A Erhardt","year":"2011","unstructured":"Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 2011; 16: 647\u2013663.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012172_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/mp.2010.81","volume":"16","author":"K Domschke","year":"2011","unstructured":"Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P et al. Neuropeptide S receptor gene \u2014 converging evidence for a role in panic disorder. Mol Psychiatry 2011; 16: 938\u2013948.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012172_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00702-006-0484-8","volume":"113","author":"A Leygraf","year":"2006","unstructured":"Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J et al. Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 2006; 113: 1921\u20131925.","journal-title":"J Neural Transm"},{"key":"BFmp2012172_CR6","first-page":"55","volume":"48","author":"J Buigues","year":"1987","unstructured":"Buigues J, Vallejo J . Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry 1987; 48: 55\u201359.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"BFmp2012172_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0022-3956(88)90070-2","volume":"22","author":"P Tyrer","year":"1988","unstructured":"Tyrer P, Shawcross C . Monoamine oxidase inhibitors in anxiety disorders. J Psychiatr Res 1988; 22 (Suppl 1): 87\u201398.","journal-title":"J Psychiatr Res"},{"key":"BFmp2012172_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1442-9071.2006.01314.x","volume":"34","author":"JL Dickinson","year":"2006","unstructured":"Dickinson JL, Sale MM, Passmore A, FitzGerald LM, Wheatley CM, Burdon KP et al. Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Exp Ophthalmol 2006; 34: 682\u2013688.","journal-title":"Clin Exp Ophthalmol"},{"key":"BFmp2012172_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/000348940511400707","volume":"114","author":"C Halpin","year":"2005","unstructured":"Halpin C, Owen G, Gutierrez-Espeleta GA, Sims K, Rehm HL . Audiologic features of Norrie disease. Ann Otol Rhinol Laryngol 2005; 114: 533\u2013538.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"BFmp2012172_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.8211186","volume":"262","author":"HG Brunner","year":"1993","unstructured":"Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA . Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578\u2013580.","journal-title":"Science"},{"key":"BFmp2012172_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.7792602","volume":"268","author":"O Cases","year":"1995","unstructured":"Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995; 268: 1763\u20131766.","journal-title":"Science"},{"key":"BFmp2012172_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/hmg\/8.4.621","volume":"8","author":"J Deckert","year":"1999","unstructured":"Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8: 621\u2013624.","journal-title":"Hum Mol Genet"},{"key":"BFmp2012172_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s004390050816","volume":"103","author":"SZ Sabol","year":"1998","unstructured":"Sabol SZ, Hu S, Hamer D . A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103: 273\u2013279.","journal-title":"Hum Genet"},{"key":"BFmp2012172_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0022-3956(00)00013-3","volume":"34","author":"EG Jonsson","year":"2000","unstructured":"Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC . A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 2000; 34: 239\u2013244.","journal-title":"J Psychiatr Res"},{"key":"BFmp2012172_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1072290","volume":"297","author":"A Caspi","year":"2002","unstructured":"Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851\u2013854.","journal-title":"Science"},{"key":"BFmp2012172_CR16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.mp.4001851","volume":"11","author":"J Kim-Cohen","year":"2006","unstructured":"Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig IW et al. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006; 11: 903\u2013913.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012172_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/sj.npp.1301359","volume":"32","author":"A Reif","year":"2007","unstructured":"Reif A, Rosler M, Freitag CM, Schneider M, Eujen A, Kissling C et al. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 2007; 32: 2375\u20132383.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2012172_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1017\/S1461145704004985","volume":"8","author":"E Maron","year":"2005","unstructured":"Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A et al. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol 2005; 8: 261\u2013266.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp2012172_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.psychres.2004.05.012","volume":"128","author":"J Samochowiec","year":"2004","unstructured":"Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 2004; 128: 21\u201326.","journal-title":"Psychiatry Res"},{"key":"BFmp2012172_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.304.5672.819","volume":"304","author":"A Gibbons","year":"2004","unstructured":"Gibbons A . American Association of Physical Anthropologists meeting. Tracking the evolutionary history of a \"warrior\" gene. Science 2004; 304: 818.","journal-title":"Science"},{"key":"BFmp2012172_CR21","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1073\/pnas.0808376106","volume":"106","author":"R McDermott","year":"2009","unstructured":"McDermott R, Tingley D, Cowden J, Frazzetto G, Johnson DD . Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation. Proc Natl Acad Sci USA 2009; 106: 2118\u20132123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2012172_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.biopsych.2006.08.007","volume":"61","author":"NI Eisenberger","year":"2007","unstructured":"Eisenberger NI, Way BM, Taylor SE, Welch WT, Lieberman MD . Understanding genetic risk for aggression: clues from the brain\u2019s response to social exclusion. Biol Psychiatry 2007; 61: 1100\u20131108.","journal-title":"Biol Psychiatry"},{"key":"BFmp2012172_CR23","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1073\/pnas.0511311103","volume":"103","author":"A Meyer-Lindenberg","year":"2006","unstructured":"Meyer-Lindenberg A, Buckholtz JW, Kolachana B, A R Hariri, Pezawas L, Blasi G et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 2006; 103: 6269\u20136274.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"BFmp2012172_CR24","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1007\/s00406-009-0065-6","volume":"259","author":"AT Gloster","year":"2009","unstructured":"Gloster AT, Wittchen HU, Einsle F, Hofler M, Lang T, Helbig-Lang S et al. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci 2009; 259 (Suppl 2): S155\u2013S166.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFmp2012172_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/mp.2011.132","volume":"17","author":"TC Eley","year":"2012","unstructured":"Eley TC, Hudson JL, Creswell C, Tropeano M, Lester KJ, Cooper P et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry 2012; 17: 236\u2013237.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012172_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1037\/a0023584","volume":"79","author":"AT Gloster","year":"2011","unstructured":"Gloster AT, Wittchen HU, Einsle F, Lang T, Helbig-Lang S, Fydrich T et al. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol 2011; 79: 406\u2013420.","journal-title":"J Consult Clin Psychol"},{"key":"BFmp2012172_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.biopsych.2012.03.035","volume":"72","author":"J Richter","year":"2012","unstructured":"Richter J, Hamm AO, Pan\u00e9-Farr\u00e9 CA, Gerlach AL, Gloster AT, Wittchen H-U et al. Dynamics of defensive reacivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder. Biol Psychiatry 2012; 72: 512\u2013520.","journal-title":"Biol Psychiatry"},{"key":"BFmp2012172_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00406-010-0099-9","volume":"260","author":"I Reinhardt","year":"2010","unstructured":"Reinhardt I, Jansen A, Kellermann T, Schuppen A, Kohn N, Gerlach AL et al. Neural correlates of aversive conditioning: development of a functional imaging paradigm for the investigation of anxiety disorders. Eur Arch Psychiatry Clin Neurosci 2010; 260: 443\u2013453.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFmp2012172_CR29","unstructured":"Kircher T, Arolt V, Jansen A, Pyka M, Reinhardt I, Kellermann T et al. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry, advance online publication, 23 August 2012 (e-pub ahead of print)."},{"key":"BFmp2012172_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1037\/0033-295X.108.1.4","volume":"108","author":"ME Bouton","year":"2001","unstructured":"Bouton ME, Mineka S, Barlow DH . A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 2001; 108: 4\u201332.","journal-title":"Psychol Rev"},{"key":"BFmp2012172_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.ajp.2009.09030410","volume":"167","author":"S Lissek","year":"2010","unstructured":"Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M, Pine DS et al. Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am J Psychiatry 2010; 167: 47\u201355.","journal-title":"Am J Psychiatry"},{"key":"BFmp2012172_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brat.2008.10.017","volume":"47","author":"S Lissek","year":"2009","unstructured":"Lissek S, Rabin SJ, McDowell DJ, Dvir S, Bradford DE, Geraci M et al. Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther 2009; 47: 111\u2013118.","journal-title":"Behav Res Ther"},{"key":"BFmp2012172_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.janxdis.2010.09.010","volume":"25","author":"O Tuescher","year":"2011","unstructured":"Tuescher O, Protopopescu X, Pan H, Cloitre M, Butler T, Goldstein M et al. Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD. J Anxiety Disord 2011; 25: 251\u2013257.","journal-title":"J Anxiety Disord"},{"key":"BFmp2012172_CR34","doi-asserted-by":"publisher","first-page":"12236","DOI":"10.1523\/JNEUROSCI.2378-09.2009","volume":"29","author":"D Mobbs","year":"2009","unstructured":"Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M et al. From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci 2009; 29: 12236\u201312243.","journal-title":"J Neurosci"},{"key":"BFmp2012172_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.1144298","volume":"317","author":"D Mobbs","year":"2007","unstructured":"Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007; 317: 1079\u20131083.","journal-title":"Science"},{"key":"BFmp2012172_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/WNR.0b013e3282f94294","volume":"19","author":"BT Lee","year":"2008","unstructured":"Lee BT, Ham BJ . Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 2008; 19: 515\u2013519.","journal-title":"Neuroreport"},{"key":"BFmp2012172_CR37","first-page":"28","volume":"4","author":"B Straube","year":"2010","unstructured":"Straube B, Chatterjee A . Space and time in perceptual causality. Front Hum Neurosci 2010; 4: 28.","journal-title":"Front Hum Neurosci"},{"key":"BFmp2012172_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2009.11.025","volume":"208","author":"D Mueller","year":"2010","unstructured":"Mueller D, Cahill SP . Noradrenergic modulation of extinction learning and exposure therapy. Behav Brain Res 2010; 208: 1\u201311.","journal-title":"Behav Brain Res"},{"key":"BFmp2012172_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.mp.4001939","volume":"12","author":"KM Myers","year":"2007","unstructured":"Myers KM, Davis M . Mechanisms of fear extinction. Mol Psychiatry 2007; 12: 120\u2013150.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012172_CR40","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1073\/pnas.1018214108","volume":"108","author":"DJ de Quervain","year":"2011","unstructured":"de Quervain DJ, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci USA 2011; 108: 6621\u20136625.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2012172_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.janxdis.2009.01.001","volume":"23","author":"MB Powers","year":"2009","unstructured":"Powers MB, Smits JA, Otto MW, Sanders C, Emmelkamp PM . Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety Disord 2009; 23: 350\u2013356.","journal-title":"J Anxiety Disord"},{"key":"BFmp2012172_CR42","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1073\/pnas.0509184103","volume":"103","author":"LM Soravia","year":"2006","unstructured":"Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U et al. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci USA 2006; 103: 5585\u20135590.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2012172_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1017\/S0033291710001248","volume":"41","author":"C Sehlmeyer","year":"2011","unstructured":"Sehlmeyer C, Dannlowski U, Schoning S, Kugel H, Pyka M, Pfleiderer B et al. Neural correlates of trait anxiety in fear extinction. Psychol Med 2011; 41: 789\u2013798.","journal-title":"Psychol Med"},{"issue":"Suppl 12","key":"BFmp2012172_CR44","first-page":"S88","volume":"10","author":"TH Svensson","year":"1987","unstructured":"Svensson TH . Stress, central neurotransmitters, and the mechanism of action of alpha 2-adrenoceptor agonists. J Cardiovasc Pharmacol 1987; 10 (Suppl 12): S88\u2013S92.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFmp2012172_CR45","doi-asserted-by":"publisher","first-page":"R868","DOI":"10.1016\/j.cub.2007.08.005","volume":"17","author":"J LeDoux","year":"2007","unstructured":"LeDoux J . The amygdala. Curr Biol 2007; 17: R868\u2013R874.","journal-title":"Curr Biol"},{"key":"BFmp2012172_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","volume":"54","author":"FG Graeff","year":"1996","unstructured":"Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF . Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 129\u2013141.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp2012172_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/026988119100500414","volume":"5","author":"JF Deakin","year":"1991","unstructured":"Deakin JF, Graeff FG . 5-HT and mechanisms of defence. J Psychopharmacol 1991; 5: 305\u2013315.","journal-title":"J Psychopharmacol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2012172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012172","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:44:59Z","timestamp":1648766699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2012172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFmp2012172"],"URL":"https:\/\/doi.org\/10.1038\/mp.2012.172","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,15]]},"assertion":[{"value":"22 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V Arolt is a member of the advisory boards and\/or gave presentations for the following companies: Astra-Zeneca, Janssen-Organon, Lilly, Lundbeck, Servier, Pfizer and Wyeth. He also received research grants from Astra-Zeneca, Lundbeck and Servier. He chaired the committee for the \u2018Wyeth Research Award Depression and Anxiety\u2019. J Deckert received in the past 3 years honoraria by Janssen, Bristol Myers-Squibb, Wyeth, Lundbeck, Astra-Zeneca and Pfizer and Grant Support by Medice, Lundbeck and AstraZeneca. T Kircher received fees for educational programs from Janssen-Cilag, Eli Lilly, Servier, Lundbeck, Bristol Myers Squibb, Pfizer and Astra-Zeneca; travel support\/sponsorship for congresses from Servier; speaker\u2019s honoraria from Janssen-Cilag; and research grants from Pfizer and Lundbeck. C Konrad received fees for educational programs from Esparma GmbH\/Aristo Pharma GmbH, Lilly Deutschland GmbH, Servier Deutschland GmbH and MagVenture GmbH. A Reif has received research support from PsyNova, and A Reif and K Domschke have received research grants from Astra Zeneca. K Domschke has received honoraria for scientific talks from Pfizer, Lilly and Bristol-Myers Squibb and has been a consultant for Johnson&Johnson. A Str\u00f6hle received research funding from Lundbeck, and speaker honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co, Lundbeck, Pfizer, Wyeth and UCB. Educational grants were given by the Stifterverband f\u00fcr die Deutsche Wissenschaft, the Berlin Brandenburgische Akademie der Wissenschaften, the Boehringer Ingelheim Fonds and the Eli Lilly International Foundation. H-U Wittchen has served as a general consultant (non-product related) for Pfizer, Organon, Servier and EssexPharma and has received grant funding for his institution from Sanofi Aventis, Pfizer, Lundbeck, Novartis, Essex Pharma, Servier and Wyeth. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}